RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Clinigen Group Stock

Clinigen Group Equity 2025

Clinigen Group Equity

0 GBP

Ticker

CLIN.L

ISIN

GB00B89J2419

In 2025, Clinigen Group's equity was 0 GBP, a 0% increase from the 0 GBP equity in the previous year.

Clinigen Group Aktienanalyse

What does Clinigen Group do?

The Clinigen Group PLC is a global pharmaceutical company specializing in the provision of rare disease and hard-to-treat disease treatments. The company was founded in 2010 with the aim of quickly and efficiently providing access to life-saving medicines for patients. However, the history of Clinigen Group goes back further. The company has its roots in Besse Medical, an American drug distributor. In 2004, Clinigen acquired Besse Medical, followed by six more distributors in the US and Europe in the following years. These acquisitions formed the foundation for the current business model. The Clinigen Group's business model is based on three pillars. The first pillar is the "Clinigen Specialty Pharmaceuticals" sector, where the company manufactures and distributes life-saving drugs for severely ill patients worldwide. The second pillar is the "Unlicensed Medicines" business, which allows patients access to unlicensed medicines that are urgently needed in specific cases. Clinigen works with pharmaceutical companies and regulatory authorities to provide these medicines within a certain framework. The third pillar is the "Clinical Trials Supply" department, which supports and streamlines clinical studies by providing medicines and services. Overall, Clinigen offers a variety of products and services, all aimed at securing access to life-saving medicines for patients. These include drugs for the treatment of cancer, infections, autoimmune diseases, neurological diseases, and rare diseases. In addition, Clinigen also offers specialized logistics and distribution services to ensure that medicines reach patients quickly and efficiently. Today, Clinigen Group is a global company headquartered in the UK with offices in North America, Europe, and Asia. The company employs over 1,000 people and works with a variety of pharmaceutical companies and regulatory authorities. An important focus is on the development of new treatment options and therapies for rare and hard-to-treat diseases. Overall, Clinigen Group has established itself as an important player in the pharmaceutical and healthcare industry. The company offers a unique business model and a wide range of products and services to secure access to life-saving medicines for patients worldwide. With its focus on innovation and collaboration with other companies and authorities, Clinigen is committed to ensuring that patients receive quick and efficient access to the medicines they need. Clinigen Group ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing Clinigen Group's Equity

Clinigen Group's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Clinigen Group's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Clinigen Group's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Clinigen Group's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Clinigen Group’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Clinigen Group stock

What is the equity of Clinigen Group this year?

Clinigen Group has equity of 0 GBP this year.

What was the equity of Clinigen Group compared to the previous year?

The equity of Clinigen Group has increased/decreased by 0% decreased compared to the previous year.

What impact does a high equity have on investors of Clinigen Group?

A high equity is advantageous for investors of Clinigen Group as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of Clinigen Group?

A low equity can be a risk for investors of Clinigen Group, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of Clinigen Group affect the company?

An increase in equity of Clinigen Group can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of Clinigen Group affect the company?

A reduction in equity of Clinigen Group can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of Clinigen Group?

Some factors that can affect the equity of Clinigen Group include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of Clinigen Group so important for investors?

The equity of Clinigen Group is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can Clinigen Group take to change the equity?

To change equity, Clinigen Group can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does Clinigen Group pay?

Over the past 12 months, Clinigen Group paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Clinigen Group is expected to pay a dividend of 0.55 GBP.

What is the dividend yield of Clinigen Group?

The current dividend yield of Clinigen Group is .

When does Clinigen Group pay dividends?

Clinigen Group pays a quarterly dividend. This is distributed in the months of April, December, April, January.

How secure is the dividend of Clinigen Group?

Clinigen Group paid dividends every year for the past 5 years.

What is the dividend of Clinigen Group?

For the upcoming 12 months, dividends amounting to 0.55 GBP are expected. This corresponds to a dividend yield of 5.93 %.

In which sector is Clinigen Group located?

Clinigen Group is assigned to the 'Health' sector.

Wann musste ich die Aktien von Clinigen Group kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Clinigen Group from 1/4/2022 amounting to 0.055 GBP, you needed to have the stock in your portfolio before the ex-date on 12/2/2021.

When did Clinigen Group pay the last dividend?

The last dividend was paid out on 1/4/2022.

What was the dividend of Clinigen Group in the year 2024?

In the year 2024, Clinigen Group distributed 0.409 GBP as dividends.

In which currency does Clinigen Group pay out the dividend?

The dividends of Clinigen Group are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Clinigen Group stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Clinigen Group

Our stock analysis for Clinigen Group Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Clinigen Group Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.